You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
|
|---|---|
| Published in |
Orphanet Journal of Rare Diseases, February 2019
|
| DOI | 10.1186/s13023-018-0982-4 |
| Pubmed ID | |
| Authors |
Elisabetta Buscarini, Luisa Maria Botella, Urban Geisthoff, Anette D. Kjeldsen, Hans Jurgen Mager, Fabio Pagella, Patrizia Suppressa, Roberto Zarrabeitia, Sophie Dupuis-Girod, Claire L. Shovlin |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 67 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 8 | 12% |
| Student > Bachelor | 8 | 12% |
| Researcher | 7 | 10% |
| Student > Doctoral Student | 5 | 7% |
| Student > Postgraduate | 4 | 6% |
| Other | 13 | 19% |
| Unknown | 22 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 40% |
| Biochemistry, Genetics and Molecular Biology | 5 | 7% |
| Nursing and Health Professions | 3 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
| Psychology | 2 | 3% |
| Other | 4 | 6% |
| Unknown | 23 | 34% |